News Focus
News Focus
icon url

bradfordbros

12/28/21 5:32 PM

#386559 RE: JTORENCE #386558

One reason could be the incredible value buying into the Brilacidin platform for $14 million. Seems very cheap to me.
icon url

MackG

01/25/22 12:00 PM

#387457 RE: JTORENCE #386558

Try reading the communication today from Leo. "Collaborative work with NIH and other researchers on Brilacidin’s broad-spectrum antiviral properties is ongoing and generating promising data, with future updates planned."